Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lecane, P. S.
Right arrow Articles by Magda, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lecane, P. S.
Right arrow Articles by Magda, D.
[Cancer Research 65, 11676-11688, December 15, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Motexafin Gadolinium and Zinc Induce Oxidative Stress Responses and Apoptosis in B-Cell Lymphoma Lines

Philip S. Lecane1, Mazen W. Karaman2, Mint Sirisawad1, Louie Naumovski1, Richard A. Miller1, Joseph G. Hacia2 and Darren Magda1

1 Pharmacyclics, Inc., Sunnyvale, California and 2 Institute for Genetic Medicine, University of Southern California, Los Angeles, California

Requests for reprints: Darren Magda, Pharmacyclics, Inc., 995 E. Arques Avenue, Sunnyvale, CA 94085. Phone: 408-774-3318; Fax: 408-328-3689; E-mail: dmagda{at}pcyc.com.

There is an emerging appreciation of the importance of zinc in regulating cancer cell growth and proliferation. Recently, we showed that the anticancer agent motexafin gadolinium (MGd) disrupted zinc metabolism in A549 lung cancer cells, leading, in the presence of exogenous zinc, to cell death. Here, we report the effect of MGd and exogenous zinc on intracellular levels of free zinc, oxidative stress, proliferation, and cell death in exponential phase human B-cell lymphoma and other hematologic cell lines. We find that increased levels of oxidative stress and intracellular free zinc precede and correlate with cell cycle arrest and apoptosis. To better understand the molecular basis of these cellular responses, gene expression profiling analyses were conducted on Ramos cell cultures treated with MGd and/or zinc acetate. Cultures treated with MGd or zinc acetate alone elicited transcriptional responses characterized by induction of metal response element–binding transcription factor-1 (MTF-1)–regulated and hypoxia-inducible transcription factor-1 (HIF-1)–regulated genes. Cultures cotreated with MGd and zinc acetate displayed further increases in the levels of MTF-1– and HIF-1–regulated transcripts as well as additional transcripts regulated by NF-E2–related transcription factor 2. These data provide insights into the molecular changes that accompany the disruption of intracellular zinc homeostasis and support a role for MGd in treatment of B-cell hematologic malignancies. (Cancer Res 2005; 65(24): 11676-88)




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
J. R. Kirshner, S. He, V. Balasubramanyam, J. Kepros, C.-Y. Yang, M. Zhang, Z. Du, J. Barsoum, and J. Bertin
Elesclomol induces cancer cell apoptosis through oxidative stress
Mol. Cancer Ther., August 1, 2008; 7(8): 2319 - 2327.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Magda, P. Lecane, Z. Wang, W. Hu, P. Thiemann, X. Ma, P. K. Dranchak, X. Wang, V. Lynch, W. Wei, et al.
Synthesis and Anticancer Properties of Water-Soluble Zinc Ionophores
Cancer Res., July 1, 2008; 68(13): 5318 - 5325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Li, E. Abdel Fattah, G. Cao, C. Ren, G. Yang, A. A. Goltsov, A. C. Chinault, W.-W. Cai, T. L. Timme, and T. C. Thompson
Glioma Pathogenesis-Related Protein 1 Exerts Tumor Suppressor Activities through Proapoptotic Reactive Oxygen Species c-Jun NH2 Kinase Signaling
Cancer Res., January 15, 2008; 68(2): 434 - 443.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. F. Baker, T. Landowski, R. Dorr, W. R. Tate, J. M.C. Gard, B. E. Tavenner, T. Dragovich, A. Coon, and G. Powis
The Antitumor Agent Imexon Activates Antioxidant Gene Expression: Evidence for an Oxidative Stress Response
Clin. Cancer Res., June 1, 2007; 13(11): 3388 - 3394.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Evans, F. Xu, M. Sirisawad, R. Miller, L. Naumovski, and P. R. O. de Montellano
Motexafin Gadolinium-Induced Cell Death Correlates with Heme oxygenase-1 Expression and Inhibition of P450 Reductase-Dependent Activities
Mol. Pharmacol., January 1, 2007; 71(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. B. Poulsen, R. Borup, N. Borregaard, F. C. Nielsen, M. B. Moller, and E. Ralfkiaer
Prognostic significance of metallothionein in B-cell lymphomas
Blood, November 15, 2006; 108(10): 3514 - 3519.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Ramos, M. Sirisawad, R. Miller, and L. Naumovski
Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation
Mol. Cancer Ther., May 1, 2006; 5(5): 1176 - 1182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.